Conclusions AM is a borderline tumor with high recurrence and malignant potential.
结论AM是复发率高、潜在恶性的交界性肿瘤。
None of the specimens contained solely receptor negative tumor cells. In 2 ovarian borderline tumors, the ER and PR positive cells were observed in regions showing relatively benignity.
未见全部由受体阴性癌细胞构成的肿瘤，卵巢交界性肿瘤的ER、PR阳性细胞多位于相对良性区域。
Moreover, low expression of the receptor was associated with greater risk of lymph node metastasis and high expression showed borderline association with lower tumor size.
此外，这种受体的表达较低与更高的淋巴结转移风险有关，而较高的表达大致与更小的肿瘤尺寸有联系。
Objective to investigate the tumor angiogenesis in benign borderline and malignant epithelial ovarian tumors and its relationship with the tumorigenesis.
目的探讨良性、界性和恶性上皮性卵巢肿瘤微血管生成状态及肿瘤微血管生成与卵巢肿瘤发生、展的关系。
This study was designed to investigate the relationship between the expression of VEGF and MVD in borderline ovarian tumor.
本研究检测卵巢交界性肿瘤组织中vegf的表达和MVD，探讨它们与临床病理特征及预后的关系。
Objective: To study the clinical features and management of borderline ovarian tumor.
前言：目的：探讨卵巢交界性肿瘤的临床特征和治疗方法。
Objective: To study the clinical features and management of borderline ovarian tumor.
前言：目的：探讨卵巢交界性肿瘤的临床特征和治疗方法。
应用推荐